首页
订购/客服:400-666-5481

Dinaciclib (SCH727965)

    
99.90%

Dinaciclib (SCH727965)

源叶(MedMol)
S80948 一键复制产品信息
779353-01-4
C21H28N6O2
396.49
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S80948-5mg买3赠1
99.90%

¥330.00

4 - - - -
S80948-25mg
99.90%

¥1010.00

8 - - - -
S80948-50mg
99.90%

¥1910.00

5 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Dinaciclib (SCH 727965) is a potent inhibitor of CDK, with IC50s of 1 nM, 1 nM, 3 nM, and 4 nM for CDK2, CDK5, CDK1, and CDK9, respectively
靶点: CDK2:1 nM (IC50);CDK5:1 nM (IC50);CDK1:3 nM (IC50);CDK9:4 nM (IC50);Apoptosis;CDK
体内研究: Dinaciclib (8, 16, 32, and 48 mg/kg, i.p.) results in tumor inhibition by 70%, 70%, 89%, and 96%, respectively; Dinaciclib (SCH 727965) is well tolerated, and the maximum body weight loss in the highest dosage group is 5%. Dinaciclib has a short plasma half-life in mouse. A dose of 5 mg/kg Dinaciclib given i.p. in mice is associated with a plasma half-life of ~0.25 hour. Treatment with Dinaciclib (SCH727965) given as twice weekly i.p. doses of 40 mg/kg for 4 weeks causes significant tumor growth inhibition (TGI) in 10/10 (100%) of low-passage subcutaneous pancreatic xenografts tested
参考文献: 1. Parry D, et al. Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor. Mol Cancer Ther. 2010 Aug;9(8):2344-53. 2. Feldmann G, et al. Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. Cancer Biol Ther. 2011 Oct 1;12(7):598-609.
溶解性: DMSO  :  50  mg/mL  (126.11  mM;  Need  ultrasonic)
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.522 ml 12.611 ml 25.221 ml
5 mM 0.504 ml 2.522 ml 5.044 ml
10 mM 0.252 ml 1.261 ml 2.522 ml
50 mM 0.05 ml 0.252 ml 0.504 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×